Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine. (Q38969264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Amir Ata Saei

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Mohammad R Rashidi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Nasser Samadi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Parisa Ghanbari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Mahsa Mohseni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Maryam Tabasinezhad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Simin Sharifi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

language of work or name

1 reference

3 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

Applied Biochemistry and Biotechnology

11 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

667-681

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12010-014-1125-6

11 March 2020

exact match

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Chemotherapy for metastatic breast cancer-report of a European expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Docetaxel: an update of its use in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Chemoresistance in human ovarian cancer: the role of apoptotic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Survivin: a promising tumor biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Review: tubulin function, action of antitubulin drugs, and new drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

The chromosomal passenger complex: guiding Aurora-B through mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Survivin: a protein with dual roles in mitosis and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Integrin signaling in cancer cell survival and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

The anti-angiogenic basis of metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Survivin as a target for new anticancer interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Nuclear or cytoplasmic expression of survivin: what is the significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

The case for survivin as a regulator of microtubule dynamics and cell-death decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

The survivin/Aurora B complex: its role in coordinating tension and attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Survivin mediates resistance to antiandrogen therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Survivin is required for stable checkpoint activation in taxol-treated HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12010-014-1125-6

10.1007/S12010-014-1125-6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

11 March 2020

1025092839

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086926%20AND%20SRC:MED&resulttype=core&format=json